chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Eczema on chest; Itchy and blotchy; Itchy and blotchy; Rash on chest,knees, inside of thighs and thin skin down near ankles; This spontaneous case was reported by a consumer and describes the occurrence of ECZEMA (Eczema on chest), RASH MACULAR (Itchy and blotchy), PRURITUS (Itchy and blotchy) and RASH (Rash on chest,knees, inside of thighs and thin skin down near ankles) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Eczema.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ECZEMA (Eczema on chest), RASH MACULAR (Itchy and blotchy), PRURITUS (Itchy and blotchy) and RASH (Rash on chest,knees, inside of thighs and thin skin down near ankles). At the time of the report, ECZEMA (Eczema on chest), RASH MACULAR (Itchy and blotchy), PRURITUS (Itchy and blotchy) and RASH (Rash on chest,knees, inside of thighs and thin skin down near ankles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided  No Treatment information were provided   Most recent FOLLOW-UP information incorporated above includes: On 16-May-2021: Follow-up received on 16-May-2021, included no new information. On 22-Jul-2021: Follow-up received on 22-JUL-2021, included no new information.
This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not provided. On 07-JUN-2018, the patient was vaccinated with a dose of oral ROTATEQ, for prophylaxis; and with the valid lot # M041181, which expired on 31-MAY-2018. The dose was inadvertently given to the patient. No adverse effects were reported in the patient after the vaccine was administered. No product quality complaint was filed.
Pt recvd 1st dose of Engerix-B DEC1991 & 2 wks p/inject pt exp hives & itching; not known if tx was given; events resolved; reporter indicated that pt has refused further doses;
2 30 seconds spells of apnea w/o cyanosis responding to stimulation t101 p/vax; has mild fever, but OK;
Fatigue, weakness, general ill-feeling, fever measured at 101.5 on Saturday, May 8.  Fatigue continued until May 13.
having ringing in my ear, just a buzzing annoying thing; This is a spontaneous report from a non-contactable consumer (patient) via Medical information team. A female patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration in Feb2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and expiration date were not reported) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. It was reported that patient have been experiencing ringing in ear, just a buzzing annoying thing on an unspecified date after the second dose of vaccine. The event was reported as non serious. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Client was 17 years old when she received J&J vaccination. Client and parent note fatigue and mild dizziness, but no other concerns. Educated that parent/child may be contacted by the State for further follow up.
Site: Pain at Injection Site-Mild, Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: there was swollen forearm opposite arm not vaccinated arm with circular bruise-Mild, Additional Details: patient got vaccine in left arm but noticed left chest pain and her right forearm near vein was stiff and swollen and bruised looking
Pt said he got some itchy hives developed 2 hours later, and it got worse overnight. He took BENADRYL for 2 days then he went to his primary care MD. MD gave him a steroid injection & pt continued taking BENADRYL. Rash has gone or gradually decreased.
2PM vaccines administered; 10PM inc temp; 2AM nausea; 4AM vomiting/nausea; episode lasted 48hrs;
This case was reported by a consumer via call center representative and described the occurrence of vaccination failure in a child male patient who received BOOSTRIX. On an unknown date, the patient received BOOSTRIX at an unknown dose. On an unknown date, unknown after receiving BOOSTRIX, the patient experienced vaccination failure (serious criteria GSK medically significant) and whooping cough (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and whooping cough were unknown. The reporter considered the vaccination failure and whooping cough to be related to BOOSTRIX. Additional details were provided as follows: This case was reported by the patient's mother. The age at the time of vaccination was not reported. The patient was forced to get the whooping cough vaccine when he changed schools. The reporter had to sign a paper acknowledging that she understood that there was a chance he might contract the disease from the vaccine. The reporter had no choice but to sign, as the school would not permit the patient to enter without being vaccinated. The patient was one of the few who got whooping cough from the vaccine. The patient missed 2 months of school. The reporter got whooping from the patient. The reporter missed a lot of work, but because the reporter owned the business she had to go to work sick for weeks. The reporter can remember how hard it was to get things done, even just go grocery shopping, because of the coughing fits, almost like convulsions, trying not to pee in pants, coughing so bad the reporter felt panicky. This case was linked to US2017GSK131351, reported by same reporter.
Delayed reaction to high dose flu vaccine. Red, swollen, warm Lt upper arm. Started 10/5/16 in PM. First time patient had the high dose Flu vaccine.
Left leg started hurting, and swoll up from my knee to my foot, and the next day was told to go to hospital. They found a blood clot in my leg .
This is a spontaneous report from a 38 year old female who on 4/6/1999, had her 1st dose of Lymerix. On 4/6/2000, her arm hurt and latr that day, her finger joint was slightly swollen and stiff. All symptoms resolved by a few days without treatment. On 5/3/99, she received her 2nd Lymerix and eperienced pain at the injection site and a heavy sensation of her arm. On approx. 6/3/99, she experienced "swelling, joint pain and stiffness of the 3 middle fingers of her left hand". These symptoms progressed and she described feeling "stiff and sore" all over. In 8/99, she developed a low-grade fever and a small, red, prickly-heat-like rash on her back and buttocks. She also had a very stiff neck, backache and constant joint pain all over. She was seen by a physician who put her on doxycycline without improvement. She saw another physician who dx'd possible rheumatic fever and placed her on amoxicillin and aspirin but her pain persisted. She also had some chest pain and was prescribed Relafen. A rhematologist was consulted and dx'd possible polyarthritis. In 12/99 she had URI and was treated with Celebrex, prednisone (which she could not tolerate) and methotrexate. On 1/6/00, pt felt good and was without arthralgias on prednisone and Vioxx but when she stopped taking both meds, her symptoms recurred. On 1/21/00, MD's dx was inflammatory arthralgias. This case is considered to be "Medically Serious" because the pt had to stop work due to joint pain.
Information has been received from a Physician, concerning an 86 year old female patient with hypertension, depression, elevated lipids, anxiety and allergy to aspirin, who on 26-FEB-2010 was vaccinated with a dose of VARIVAX (dose not reported) (lot number 665180/1133Y). Concomitant therapy included Alprazolam, Hydrocodone, Sertraline HCl, Propranolol HCl and vitamin D (unspecified). It was reported that on 26-FEB-2010. The Medical Assistant administered to patient VARIVAX instead of ZOSTAVAX by mistake. At the time of reporting, no adverse effects occurred. Follow-up information has been received from a Medical Assistant, who stated that the VARIVAX and the ZOSTAVAX were stored closely together in the same refrigerator. The Medical Assistant also stated that the Nurse administered the VARIVAX due to medication error. The office had a plan to correct the vaccine storage situation. Additional information is not expected.
Rash appeared about 1 inch below injection site on second day after the booster vaccine.
Expired dose administered; This case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 72-year-old female patient who received HAB (Twinrix) (batch number X239D, expiry date 7th August 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 27th September 2022, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 27th September 2022, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 28-Sept-2022 Reporter's comment: The reporter consented to follow-up. Additional supportive information: The patient received an expired dose of Twinrix, which led to expired vaccine used.
Patient had small patch of papulosquemous dermatitis in left parascapular area of skin over back.  On 7/6/07 had Tdap vaccine and within days, localized dermatitis became wide spread over entire trunk persisting for weeks.
I developed a splotchy red rash on the front of my right shoulder, down the center of my chest, and on the left side of my left breast. I did not have any rash on my right arm at the injection site. It looked like a moderate sunburn. It did not itch or bother me in any way., but was warm to the touch.  Each of the three splotches is approximately the size of my palm. At the time that I first noticed the rash, my temperature was up to 100.1. The previous day, my temperature had gone as high as 101.0, but came down after taking Tylenol. I had stopped the Tylenol on the morning of February 15, thinking the fever was over. But by 7:30 PM, my temperature was going back up again, and that is when I noticed the rash. As of 4 PM on February 16, the rash is definitely paler, but still there. In addition, another splotch developed on the right side of my back, again, the size of my palm. I contacted the urgent care center where I was vaccinated, who told me I could come in to have it looked at, but they were about to close. They offered the option of a Tele visit, but no one called me back within two hours. By that time, the rash had started to fade, so I canceled the Tele visit. I took another dose of extra strength Tylenol the morning of February 16. I have not taken another dose since then, and the rash has not gotten any worse. My fever has not returned.
Slight fever of 103; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Slight fever of 103) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Slight fever of 103). At the time of the report, PYREXIA (Slight fever of 103) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103 (High) Unknown.         No concomitant medication reported. Treatment information not provided.   Action taken with mRNA-1273 in response to the events was not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
pt recv vax & exp an excessive sting while pt was injected w/pain @ site following;no tx was given;
I threw up my dinner that night, had 4 terrible shaking Chills over that weekend and continued  chill for about a week, weakness in legs, fatigue,  sleeping for hours, no energy, itchy skin, no appetite (lost 8 pounds), continued mental disorientation and unusual forgetfulness, also inablity to type correctly or to tell stories that I had just  rehearsed,   I also lost 20% of hearing in left ear,  After 5 weeks I am about 95% OK physically, but still very slow with brain power and typing.
positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer.  A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 01Apr2021 (Lot Number: ER8734) (at age of 43-year-old) as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient received the vaccine the first day of this month (01Apr2021). She felt bad Thursday (01Apr2021), and bad Friday. Saturday and Sunday (4Apr2021) she was not able to smell. She was still unable to smell. She only got one dose of the vaccine. Today (6Apr2021) she went to get a COVID test, and she tested positive. She has a little cough. She didn't take any other medications. The patient underwent lab tests and procedures which included sars-cov-2 test positive: positive on 06Apr2021.  The event outcome was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Itchy rash on both hands both forearms . Felt a warm body flush like an iv contrast . Mouth tasted metallic like when injected w iv contrast. Breath felt like had trouble catching breath but didn't last or intensify so I didn't go seek medical attention. Rash still remains into following day.  Injection Arm slightly swollen, sore.
Mistakenly gave 3rd dose of Shingrix.  No adverse reactions stated by patient.  He thought it was his second and I did not accurately detect his first shot given on 02/15/2021
I did not have any problems with the first two doses of the vaccine. Fours day after the third dose I fell down because I was dizzy. I called EMS and they said it was Vertigo when I went to the ER. I sometimes feel quivering in my left shoulder. I was experiencing dizziness and one day I felt left sided weakness and extreme dizziness. I fell down again and I was hospitalized for four days on 01/02/2022. I was advised to see a Neurologist and a Rheumatologist. My blood sugar has been running higher than normal and my blood pressure has been unpredictable. My body feels heavy on the left side. I cannot stand or walk without holding onto something with my right side. I am still experiencing the twitching in my shoulder. It has been over three weeks and there has been little relief. I feel worse in the morning and sometimes in the afternoon it improves. I was unable to get out of bed yesterday.
Patient describes persistent arm pain around injection site that has radiated through her arm, and is causing her other arm to hurt as well.
COVID positive; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (COVID positive) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced COVID-19 (COVID positive). At the time of the report, COVID-19 (COVID positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Feb-2021, SARS-CoV-2 antibody test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were reported No treatment medication were reported.
Constant tinnitus alternating in both ears, varying in intensity, the sound is whining. Started on 4/28/2021 upon waking up.
Patient received shot around 12:40pm on 9/21/13. She returned home. Approximately 2:30-3pm she began feeling short of breath. She says it was not severe but did last approximately 3 hours. She says she now has no symptoms or difficulty and feels fine as of 12:30pm today (9/22/13). She exhibits no symptoms of illness or even soreness at injection site. No other symptoms were present.
Suspected vaccination failure/second /shot / in May of 2019/ in / 2021 / Shingles; Shingles rash; Rash; This case was reported by a consumer via call center representative and described the occurrence of suspected vaccination failure in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In May 2019, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, the patient received the 1st dose of Shingrix. On 28th May 2021, 2 years after receiving Shingrix and more than 2 years after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and rash. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and rash were not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and rash to be related to Shingrix and Shingrix.  Additional details provided were as follows: The age at vaccination was unknown for 1st dose of Shingrix. This case was reported by the patient herself. The patient had her second Shingrix shot in unknown deltoid 2 years ago. In May 2021, she experienced Shingles and had shingles rash for over 12 weeks. It was not resolved. This case was considered as suspected vaccination failure since the details regarding laboratory test confirming shingles were unknown at the time of reporting. The patient was advised to take follow-up with her health care professional. No batch number and expiry date for the vaccine was provided. The reporter declined to provide health care professional information and did not consent to follow-up.
Information has been received from a published article. This literature case was initially reported on 29-MAR-2010. This article concerned 32 patient's (8 male and 24 female) aged between one to 57 years (mean age of patients was 29 years). The patients received a RECOMBIVAX HB vaccine, manufacturer, batch number, route and site not reported, on unreported dates. This report concerns patient #9 of 32, a 12 year old female. On an unreported date between 1982 and 2009, one to fifteen days post vaccination, the patient experienced uveitis (mean time to onset of three days). The uveitis was reported to occur after the first vaccination in 15 patients, after the second vaccination on three patients and after the third vaccination in three patients. The duration of the uveitis was not reported for nine patients. One patient had recurrent uveitis after the first and second doses of vaccine. One patient had recurrent uveitis after the second and third doses. Patient outcome had not been reported. A 12 year old female on an unspecified date was vaccinated with a dose of RECOMBIVAX HB vaccine (lot number, route and site not reported). There was no concomitant medication. On an unspecified date after vaccination, the patient developed uveitis. At the time of the report, the patient's outcome was not reported. The authors stated the RECOMBIVAX HB vaccine may have a possible association with the development of uveitis in some patients. Immune complex deposition and adjuvant effects are potential pathogenic mechanisms. Uveitis was considered to be an other important medical event. Other business partner numbers include E2010-02312. Additional information  has been requested. The article also discussed the experience of an additional 31 patients while on therapy with RECOMBIVAX HB vaccine (WAES #1004USA01716, WAES # 1004USA02327 to WAES # 1004USA02333, WAES # 1004USA02335 to WAES # 1004USA02357). A copy of the published article is attached as further documentation of the patient's experience.
"The day after the 2nd dose, I began feeling sick and was experiencing emotional problems. I had a headache and nausea. I began having bad thoughts, with thoughts of self-harm and feeling that I wanted to die. I was very tearful, felt very spacy and dissociated, and had difficulty standing."
PT HAS A LARGE RED RAISED AREA 3.5 INCHES WIDE AND 5 INCHES LONG 1/8 INCH HIGH VERY WARM TO TOUCH. PT WAS GIVEN DEPO MEDROL 40MG IM. PT TO RETURN TO DOCTORS OFFICE OR TO THE ER IF IT GETS WORSE.
This spontaneous report was received from a registered nurse refers to a patient of unknown age and gender. On 08-NOV-2012 the patient was vaccinated with a dose of VARIVAX (Merck) (lot # 668614/1276Z), expiration date 30-SEP-2012) which was expired. No concomitant medications were reported. No adverse effect reported. No other information provided. Additional information has been requested.
he received both doses of the Pfizer-BioNTech Covid 19 Vaccine in Jan2021. 2 months ago, he had dental work done; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 81 year-old male patient received bnt162b2 (BNT162B2), administration date Jan2021 (Batch/Lot number: unknown) as dose 2, single and administration date Jan2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: TOOTH DISORDER (non-serious), outcome "unknown", described as "he received both doses of the Pfizer-BioNTech Covid 19 Vaccine in Jan2021. 2 months ago, he had dental work done". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of tooth disorder.  Additional information: Reporter stated that he happily wants to report that he doesn't have COVID, but he had the shots in him and he had a unique experience to report. He took the first two shots of the COVID vaccine back in Jan2021 and he went through all these months without a problem. He decided to go for a test, an antibody test, so he went to one it came back that he had 0. He then started thinking what could of caused it to be 0. He underwent a lot of dental work and was told to take amoxicillin so he had amoxicillin during that period, late in that period, with Pfizer's COVID vaccine and upon seeing that he was void of antibodies his doctor said to go for a third dose and so he went for the third. While he was waiting for those three weeks he went back for the test, for antibodies, and uniquely at that time he was still having trouble with his teeth and the dentist put him back on amoxicillin. He then went for the test to see how much antibodies he had and it was 0 after three the weeks. There was correlation with the amoxicillin. He said that this is the whole situation and he was only looking for an answer. He needs to know whether he should take another COVID vaccine, a 4th, because he had no antibodies whatsoever or what he should do.   No follow-up attempts are possible. No further information is expected.